NCR3LG1 and neoplasm: A study of patients with ovarian carcinoma has shown a loss of expression of the activating receptor NKp30 in tumor-associated NK cells, and this decrease has been associated with the presence of B7-H6, both in the soluble form and on the surface of the tumor cells [73].